We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Hettich Presents Small, Benchtop, and Automation-Ready Centrifuges

By LabMedica International staff writers
Posted on 28 Jul 2026

Hettich North America is showcasing a range of centrifugation technologies for clinical laboratory workflows at the ADLM 2026 Clinical Lab Expo. More...

Visitors to booth 2840 can explore compact, benchtop, specialty, and automation-compatible systems designed to accommodate varying sample volumes and testing applications.

The company’s small centrifuge portfolio combines compact footprints with rapid separation for low-volume and time-sensitive testing. Featured options include the EBA Series for blood bank, hematology, STAT, core laboratory, and physician-office applications, as well as the HAEMATOKRIT 200 for rapid hematocrit determination.

Hettich is also presenting general-purpose benchtop systems that accommodate a broad range of tubes, plates, rotors, and accessories. These medium- to high-capacity centrifuges are designed to help laboratories meet varying throughput requirements without relying on multiple application-specific instruments.

For cytology workflows, the Hettich Cyto-System allows laboratories to use a 12-place cytology clip rotor with the ROTOFIX 32 A or UNIVERSAL 320 benchtop centrifuge. The rotor includes a certified biocontainment lid and supports several funnel formats, enabling laboratories to process common tubes, microplates, and cytology preparations on the same platform.

The exhibit additionally includes automation-friendly centrifuges intended for integration into robotic laboratory workflows. Hettich’s automated portfolio spans compact and higher-capacity models, including the MIKRO 220 ROBOTIC, SBS 300 ROBOTIC, ROTINA 380 ROBOTIC, and ROTANTA 460 ROBOTIC.

Through its ADLM 2026 showcase, Hettich is demonstrating how laboratories can select and combine centrifuges, rotors, and accessories to improve turnaround times, expand testing flexibility, and streamline routine sample-processing workflows.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Manual Pipetting Aid
Pipette Controllers macro
New
Gold Member
Quantitative lmmunoassay Test Menu
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.